HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 5.56% up in after-hours trading
HCW Biologics is trading at $1.33, up 5.56% after hours, with no verified October 13 announcement or other clear catalyst identified. - It closed the regular...
🔴 HCW Biologics is trading 10% down
HCW Biologics is trading at $1.33, down 10.13% on October 13, 2026; no clear announcement explains the decline. - October 9 company news described FDA...
🔴 HCW Biologics is trading 8.1% down
HCW Biologics is trading at $1.36, down 8.09%, with no specific company announcement identified to explain the October 13 decline. - The latest reported...
🔴 HCW Biologics is trading 10.1% down in pre-market
HCW Biologics is trading at $1.33, down 10.1%, with no company-specific explanation identified for the pre-market decline. - This compares with the provided...
🔴 HCW Biologics is trading 6.8% down in pre-market; catalyst unconfirmed
HCW Biologics is trading 6.8% down at $1.38 in pre-market on October 13, 2026, versus the provided previous close of $1.48; the catalyst remains unconfirmed. -...
🔴 HCW Biologics is trading 6% down — reason unconfirmed
HCW Biologics is trading at $1.51, down 5.63%, during the October 12, 2026 session; the reason for the decline remains unconfirmed. - No company-specific...
HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?
Shares of HCW Biologics surged 13% to $1.73 after the company disclosed that the FDA provided formal guidance on how to advance its lead cancer drug candidate...
🟢 HCW Biologics is trading 13% up today after FDA guidance on cancer-study IND next steps
HCW Biologics is trading at $1.73 (+12.95%) after a recent FDA Type B meeting provided guidance on next steps for a first-in-human solid-tumor study. - The...
🟢 HCW Biologics is trading 6.5% up today after FDA guidance clarified IND next steps
HCW Biologics is trading at $1.63, up +6.54%, after FDA Type B meeting guidance clarified next steps for its planned first-in-human solid-tumor study of...
🔴 HCW Biologics is trading 5% down in pre-market
HCW Biologics is trading at $1.48, down 5.34% in pre-market, with no clear company-specific announcement dated October 8 explaining the decline. - Recent...
🔴 HCW Biologics is trading 7.1% down
HCW Biologics is trading 7.1% down at $1.56 on October 5, 2026, with no confirmed company announcement or clear catalyst identified. - The price continued...
🔴 HCW Biologics is trading 7.7% down in pre-market with no confirmed catalyst
HCW Biologics is trading at $1.55, down 7.7% in pre-market on October 5, 2026; the cause remains unconfirmed. - Shares closed at $1.68 October 2, after falling...
🟢 HCW Biologics is trading 7% up in pre-market with no clear catalyst identified
HCW Biologics is trading at $1.83, up 7.02%, in pre-market on October 1, with no clear company-specific catalyst identified. - Its latest news-release page...
🔴 HCW Biologics is trading 5% down in pre-market with no clear catalyst identified
HCW Biologics is trading at $1.73, down 5.04%, with no clear catalyst identified for the September 29 pre-market decline. - No new company-specific...
🔴 HCW Biologics is trading 5.5% down in after-hours trading amid broader risk-off sentiment
HCW Biologics is trading 5.5% lower at $1.72 after-hours, with broader market weakness as possible context; no company-specific announcement explaining the...
🔴 HCW Biologics is trading 11.36% down today as oil and Treasury yields revive inflation fears
HCW Biologics is trading 11.36% down at $1.71, with broader macro risk-off sentiment the clearest available context for the decline. - Rising oil prices and...
🔴 HCW Biologics is trading 6.7% down as oil and bond yields revived inflation concerns
HCW Biologics is trading at $1.80, down 6.74%, amid broader risk-off pressure. - Reuters reported September 28 that shares were mostly lower as rising oil...
🔴 HCW Biologics is trading 5.18% down in pre-market after $1.5 million private placement
HCW Biologics is trading at $1.83, down 5.18%, in pre-market after its September 24 announcement of a $1.5 million private placement with an existing...
🔴 HCW Biologics is trading 5% down in after-hours trading after $1.5 million dilutive private placement
HCW Biologics is trading at $1.83, down 5.18%, in after-hours trading, as dilution concerns follow its private-placement announcement. - On September 25, 2026,...
🔴 HCW Biologics is trading 5.41% down today as $1.5 million placement raises dilution concerns
HCW Biologics is trading 5.41% lower at $1.88 after investors reacted to its September 24, 2026 announcement of a $1.5 million private placement. - The...